| The vestibular evoked myogenic potentials (VEMP) score: a promising tool for evaluation of brainstem involvement in multiple sclerosis T Gabelić, M Krbot Skorić, I Adamec, B Barun, I Zadro, M Habek European Journal of Neurology 22 (2), 261-e21, 2015 | 61 | 2015 |
| Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis T Gabelic, DP Ramasamy, B Weinstock-Guttman, J Hagemeier, ... American Journal of Neuroradiology 35 (1), 106-112, 2014 | 60 | 2014 |
| Auditory evoked potentials and vestibular evoked myogenic potentials in evaluation of brainstem lesions in multiple sclerosis A Ivanković, VN Mađarić, K Starčević, MK Skorić, T Gabelić, I Adamec, ... Journal of the neurological sciences 328 (1-2), 24-27, 2013 | 53 | 2013 |
| Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome T Gabelić, M Radmilović, V Posavec, A Škvorc, M Bošković, I Adamec, ... Acta Neurologica Belgica 113, 13-17, 2013 | 38 | 2013 |
| Electroencephalographic response to different odors in healthy individuals: A promising tool for objective assessment of olfactory disorders M Krbot Skorić, I Adamec, AB Jerbić, T Gabelić, S Hajnšek, M Habek Clinical EEG and neuroscience 46 (4), 370-376, 2015 | 37 | 2015 |
| Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria M Habek, T Pavičić, B Ruška, I Pavlović, T Gabelić, B Barun, I Adamec, ... Multiple sclerosis and related disorders 25, 99-103, 2018 | 32 | 2018 |
| Vestibular evoked myogenic potentials and MRI in early multiple sclerosis: Validation of the VEMP score L Crnošija, MK Skorić, T Gabelić, I Adamec, M Habek Journal of the neurological sciences 372, 28-32, 2017 | 31 | 2017 |
| Recommendations for diagnosis and management of multiple sclerosis VB Kes, I Zavoreo, V Šerić, VV Solter, M Cesarik, S Hajnšek, AV Grbelja, ... Acta Clin Croat 51 (1), 117-135, 2012 | 31 | 2012 |
| Influence of delaying ocrelizumab dosing in multiple sclerosis due to COVID-19 pandemics on clinical and laboratory effectiveness B Barun, T Gabelić, I Adamec, A Babić, H Lalić, D Batinić, MK Skorić, ... Multiple Sclerosis and Related Disorders 48, 102704, 2021 | 29 | 2021 |
| Autonomic symptom burden can predict disease activity in early multiple sclerosis MK Skorić, L Crnošija, T Gabelić, B Barun, I Adamec, A Junaković, ... Multiple sclerosis and related disorders 28, 250-255, 2019 | 28 | 2019 |
| Delay in the diagnosis of multiple sclerosis in Croatia I Adamec, B Barun, T Gabelić, I Zadro, M Habek Clinical neurology and neurosurgery 115, S70-S72, 2013 | 28 | 2013 |
| The role of cervical and ocular vestibular-evoked myogenic potentials in the follow-up of vestibular neuritis I Adamec, MK Skorić, J Handžić, AK Barušić, I Bach, T Gabelić, M Habek Clinical EEG and neuroscience 45 (2), 129-136, 2014 | 25 | 2014 |
| Postural orthostatic tachycardia predicts early conversion to multiple sclerosis after clinically isolated syndrome M Habek, M Krbot Skorić, L Crnošija, T Gabelić, B Barun, I Adamec European neurology 77 (5-6), 253-257, 2017 | 24 | 2017 |
| Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue M Krbot Skorić, L Crnošija, I Adamec, B Barun, T Gabelić, T Smoljo, ... Clinical autonomic research 29, 321-328, 2019 | 23 | 2019 |
| Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: effects of disease modifying therapies M Habek, C Željko, AS Mlakar, K Bendelja, D Rogić, I Adamec, B Barun, ... Multiple Sclerosis and Related Disorders 59, 103682, 2022 | 18 | 2022 |
| Clinical neurophysiology of multiple sclerosis M Habek, I Adamec, B Barun, L Crnošija, T Gabelić, M Krbot Skorić Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer …, 2017 | 18 | 2017 |
| Primary position upbeat nystagmus I Adamec, T Gabelić, M Krbot, D Ozretić, I Milivojević, M Habek Journal of Clinical Neuroscience 19 (1), 161-162, 2012 | 18 | 2012 |
| Effectiveness and safety of alemtuzumab in the treatment of active relapsing–remitting multiple sclerosis: a multicenter, observational study G Brecl Jakob, B Barun, S Gomezelj, T Gabelić, S Šega Jazbec, I Adamec, ... Neurological sciences, 1-7, 2021 | 16 | 2021 |
| Longitudinal assessment of autonomic nervous system in patients with first demyelinating event suggestive of multiple sclerosis M Habek, L Crnošija, T Gabelić, B Barun, I Adamec, A Junaković, B Ruška, ... European journal of neurology 26 (11), 1377-1383, 2019 | 16 | 2019 |
| Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab M Habek, D Piskač, T Gabelić, B Barun, I Adamec, MK Skorić Multiple Sclerosis and Related Disorders 62, 103798, 2022 | 14 | 2022 |
